C1qB and clusterin mRNA increase in association with neurodegeneration in sporadic amyotrophic lateral sclerosis

Neuroscience Letters

Volumn 271, Issue 1, 1999, Pages 65-67

  Grewal, Raji P ^a,b,c   Morgan, Todd E ^b,c   Finch, Caleb E ^a,b,c  

^a Department of Surgery Div Trauma Critical Care Univ S   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Amyotrophic lateral sclerosis; Clusterin; Complement; Inflammation; MRNA; Neurodegeneration

Indexed keywords

CLUSTERIN; COMPLEMENT COMPONENT C1Q; MESSENGER RNA;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOPATHOGENESIS; IN SITU HYBRIDIZATION; INFLAMMATION; MOTOR CORTEX; NERVE CELL DEGENERATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TEMPORAL CORTEX;

ADOLESCENT; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; CEREBRAL CORTEX; CLUSTERIN; COMPLEMENT C1Q; COMPLEMENT INACTIVATOR PROTEINS; GENE EXPRESSION REGULATION; GLYCOPROTEINS; HUMANS; MOLECULAR CHAPERONES; NERVE DEGENERATION; REFERENCE VALUES; RNA, MESSENGER; SOMATOSENSORY CORTEX; SPINAL CORD; TEMPORAL LOBE; TRANSCRIPTION, GENETIC;

EID: 0033551794     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00496-6     Document Type: Article

References (18)

1. Danik M., Chabot J.G., Mercier C., Benabid A.L., Chauvin C., Quirion R., Suh M. Human gliomas and epileptic foci express high levels of a mRNA related to rat testicular sulfated glycoprotein 2, a purported marker of cell death. Proc. Natl. Acad. Sci. USA. 88:1991;8577-8581.
2. Finch C.E. Clusterin in Normal Brain Functions and During Neurodegeneration. 1999;R.G. Landes Company, Austin, TX. pp. 1-123.
3. Johnson S.A., Lampert-Etchells M., Pasinetti G.M., Rozovsky I., Finch C.E. Complement mRNA in the mammalian brain: responses to Alzheimer's disease and experimental brain lesioning. Neurobiol. Aging. 13:1992;641-648.
4. Humphreys D.T., Carver J.A., Easterbrook-Smith S.B., Wilson M.R. Clusterin has chaperone-like activity similar to that of small heat shock proteins. J. Biol. Chem. 274:1999;6875-6881.
5. Kawamata T., Akiyama H., Yamada T., McGeer P.L. Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am. J. Pathol. 140:1992;691-707.
6. Kerkhoff H., Troost D., Louwerse E.S., van Dijk M., Veldman H., Jennekens F.G. Inflammatory cells in the peripheral nervous system in motor neuron disease. Acta Neuropathol. (Berl.). 85:1993;560-565.
7. Liu L., Tornqvist E., Mattsson P., Eriksson N.P., Persson J.K.E., Morgan B.P., Aldskogius H., Svensson M. Complement and clusterin in the spinal cord dorsal horn and gracile nucleus following sciatic nerve injury in the adult rat. Neuroscience. 68:1995;167-179.
8. May P.C., Finch C.E. Sulphated glycoprotein 2: new relationship of this multifunctional protein to neurodegeneration. Trends Neurosci. 15:1992;391-396.
9. McGeer P.L., Kawamata T., Walker D.G. Distribution of clusterin in Alzheimer brain tissue. Brain Res. 579:1992;337-341.
10. Pasinetti G.M., Johnson S.A., Lampert-Etchells M., Finch C.E. Complement C1qB and C4 mRNAs responses to lesioning in rat brain. Exp. Neurol. 118:1992;117-125.
11. Rozovsky I., Morgan T.E., Willoughby D.A., Dugich-Djordevich M.N., Pasinetti G.M., Johnson S.A., Finch C.E. Selective expression of clusterin (SGP-2) and complement Clq and C4 during responses to neurotoxins in vivo and in vitro. Neuroscience. 62:1994;741-758.
12. Rowland L.P. Amyotrophic lateral sclerosis: theories and therapies. Ann. Neurol. 35:1994;129-130.
13. Sekizawa T., Openshaw H., Ohbo K., Sugamura K., Itoyama Y., Niland J.C. Cerebrospinal fluid interleukin 6 in ainyotrophic lateral sclerosis: immunological parameter and comparison with inflammatory and non-inflammatory central nervous system diseases. J. Neurol. Sci. 154:1998;194-199.
14. Shen Y., Li R., McGeer E.G., McGeer P.L. Neuronal expression of niRNAs for complement proteins of the classical pathway in Alzheimer brain. Brain Res. 769:1997;391-395.
15. Smith G.R., Hamilton S., Hofinann F., Schneider T., Nastainczyk W., Birnbaumer L., Stefani E., Appel S.H. Serum antibodies to L-type calcium channels in patients with amyotrophic lateral sclerosis. N. Engl. J. Med. 327:1992;1721-1728.
16. Viard I., Wehrli P., Jornot L., Bullani R., Vechieffi J.L., Schifferli J.A., Tschopp J., French L.E. Clusterin gene expression mediates resistance to apoptotic cell death induced by heat shock and oxidative stress. J. Invest. Dermatol. 112:1999;290-296.
17. Storrs S.B., Kolb W.P., Olson M.S. Clq binding and C1 activation by various isolated cellular membranes. J. Immunol. 131:1983;416-422.
18. Wong P.C., Rothstein J.D., Price D.L. The genetic and molecular mechanisms of motor neuron disease. Curr. Opin. Neurobiol. 8:1998;791-799.